This event has already occurred. Please check back to the website for a replay of the webinar.
Healthcare often seems to be a monolith – ever-changing and yet somehow the same. Large pharma companies buy up new drugs, medical device and healthcare data businesses promise efficiency revolutions, insurers grind along like tectonic plates shifting across the continent, and hospitals privatize.
But big change is afoot. New regulatory changes are prompting a spate of IPOs on the Hong Kong stock exchange. For the first time, a majority of Americas want public healthcare and the US government may put the screws on drug prices. Disruptive technology giants like Amazon are looking to get their foot in the healthcare door, while new clinic models have become prime private equity hunting ground, with companies like Mednax in the news as takeout targets for Carlyle Group, amongst others.
What’s driving this sector-wide influx of interest and what does the M&A shake-out look like? Please join us June 7 as we discuss the forces behind current healthcare disruption. Topics will include:
- Rise of new immunotherapy drugs and biosimilars and healthcare market fallout
- Drivers behind the spate of listings on the Hong Kong stock exchange
- Private equity interest in behavioral and retail clinic chains
- Political headwinds and tailwinds, such as US shift in public opinion toward single-payer health system and what the US can learn from EMEA
Meet the Panelists
Partner, Life Sciences; Goodwin Procter
Laurie Burlingame is a partner in the firm’s nationally recognized Life Sciences Practice Group. She represents private and public companies across the spectrum of the life sciences industry, including pharmaceuticals, medical devices, diagnostics and biological materials. Ms. Burlingame also represents leading venture capital firms focused on the life sciences industry in connection with their portfolio company investments. Ms. Burlingame often serves as outside general counsel to her clients, closely advising management teams and boards of directors on a wide variety of matters throughout the company’s life cycle, including formation and founder issues, venture capital financings, public offerings, mergers and acquisitions, licensing transactions, strategic collaborations, commercial transactions, corporate governance and other general corporate matters.
Director, Healthcare M&A; PwC
Joe is a Director in the PwC Healthcare M&A team, based in London. He has over ten years of Corporate Finance experience, having previously been at NM Rothschild & Sons. He has advised on a wide range of healthcare and other transactions. From 2012-2014, Joe acted as seconded Assistant Secretary to the UK Takeover Panel and oversaw a large number of transactions subject to the Takeover Code. Joe qualified as a lawyer at Slaughter and May after completing a degree in Classics at Cambridge University.
Managing Director; Raymond James
Mr. Phelps has been with Raymond James for 10 years. He rejoined Raymond James in 2016 after two years with Deutsche Bank Securities as a Director with senior coverage responsibility for the pharmacy supply chain and physician services. He has helped facilitate over 40 M&A transactions in his career as an advisor with an aggregate value of over $10 billion. Mr. Phelps holds a BA in Economics, cum laude, from the University of Alabama and an MS in Finance from Vanderbilt University.
Life Sciences Advisor, CEO & Founder; KKH Advisors
Kimberly is founder & CEO of KKH Advisors, a life sciences and digital health advisory firm. She was previously Senior Director at FTI Consulting, Healthcare Capital Markets Communications, where she advised a broad range of clients from Fortune 500 to early-stage companies on IPO communications, business transformation, corporate and executive positioning, crisis and issues management, and financial communications. She is also on the digital health advisory board at Array Ventures, a San Francisco-based VC fund, and an advisor to Savonix and Univfy, two digital health companies founded by Stanford clinicians.
Merrill Insight™ Video | Healthcare Spotlight: Patent Cliffs, Pricing and Politics is co-sponsored by BioSpace.
For over 30 years, BioSpace has championed the Life Sciences industry as a digital hub for news and careers. We provide essential insights, opportunities and tools to connect the innovative organizations and talented professionals who advance health and quality of life across the globe.